Eintrag weiter verarbeiten
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
Gespeichert in:
Zeitschriftentitel: | International Journal of Molecular Sciences |
---|---|
Personen und Körperschaften: | , |
In: | International Journal of Molecular Sciences, 20, 2019, 2, S. 350 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
MDPI AG
|
Schlagwörter: |
author_facet |
van der Kouwe, Emiel Staber, Philipp van der Kouwe, Emiel Staber, Philipp |
---|---|
author |
van der Kouwe, Emiel Staber, Philipp |
spellingShingle |
van der Kouwe, Emiel Staber, Philipp International Journal of Molecular Sciences RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis |
author_sort |
van der kouwe, emiel |
spelling |
van der Kouwe, Emiel Staber, Philipp 1422-0067 MDPI AG Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis http://dx.doi.org/10.3390/ijms20020350 <jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p> RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia International Journal of Molecular Sciences |
doi_str_mv |
10.3390/ijms20020350 |
facet_avail |
Online Free |
finc_class_facet |
Chemie und Pharmazie Physik Informatik Biologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjAwMjAzNTA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjAwMjAzNTA |
institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 |
imprint |
MDPI AG, 2019 |
imprint_str_mv |
MDPI AG, 2019 |
issn |
1422-0067 |
issn_str_mv |
1422-0067 |
language |
English |
mega_collection |
MDPI AG (CrossRef) |
match_str |
vanderkouwe2019runx1etoattackingtheepigenomeforgenomicinstableleukemia |
publishDateSort |
2019 |
publisher |
MDPI AG |
recordtype |
ai |
record_format |
ai |
series |
International Journal of Molecular Sciences |
source_id |
49 |
title |
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_unstemmed |
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_full |
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_fullStr |
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_full_unstemmed |
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_short |
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_sort |
runx1-eto: attacking the epigenome for genomic instable leukemia |
topic |
Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis |
url |
http://dx.doi.org/10.3390/ijms20020350 |
publishDate |
2019 |
physical |
350 |
description |
<jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p> |
container_issue |
2 |
container_start_page |
0 |
container_title |
International Journal of Molecular Sciences |
container_volume |
20 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792332133882134531 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T13:52:01.025Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=RUNX1-ETO%3A+Attacking+the+Epigenome+for+Genomic+Instable+Leukemia&rft.date=2019-01-16&genre=article&issn=1422-0067&volume=20&issue=2&pages=350&jtitle=International+Journal+of+Molecular+Sciences&atitle=RUNX1-ETO%3A+Attacking+the+Epigenome+for+Genomic+Instable+Leukemia&aulast=Staber&aufirst=Philipp&rft_id=info%3Adoi%2F10.3390%2Fijms20020350&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792332133882134531 |
author | van der Kouwe, Emiel, Staber, Philipp |
author_facet | van der Kouwe, Emiel, Staber, Philipp, van der Kouwe, Emiel, Staber, Philipp |
author_sort | van der kouwe, emiel |
container_issue | 2 |
container_start_page | 0 |
container_title | International Journal of Molecular Sciences |
container_volume | 20 |
description | <jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p> |
doi_str_mv | 10.3390/ijms20020350 |
facet_avail | Online, Free |
finc_class_facet | Chemie und Pharmazie, Physik, Informatik, Biologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjAwMjAzNTA |
imprint | MDPI AG, 2019 |
imprint_str_mv | MDPI AG, 2019 |
institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11 |
issn | 1422-0067 |
issn_str_mv | 1422-0067 |
language | English |
last_indexed | 2024-03-01T13:52:01.025Z |
match_str | vanderkouwe2019runx1etoattackingtheepigenomeforgenomicinstableleukemia |
mega_collection | MDPI AG (CrossRef) |
physical | 350 |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | MDPI AG |
record_format | ai |
recordtype | ai |
series | International Journal of Molecular Sciences |
source_id | 49 |
spelling | van der Kouwe, Emiel Staber, Philipp 1422-0067 MDPI AG Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis http://dx.doi.org/10.3390/ijms20020350 <jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p> RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia International Journal of Molecular Sciences |
spellingShingle | van der Kouwe, Emiel, Staber, Philipp, International Journal of Molecular Sciences, RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia, Inorganic Chemistry, Organic Chemistry, Physical and Theoretical Chemistry, Computer Science Applications, Spectroscopy, Molecular Biology, General Medicine, Catalysis |
title | RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_full | RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_fullStr | RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_full_unstemmed | RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_short | RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
title_sort | runx1-eto: attacking the epigenome for genomic instable leukemia |
title_unstemmed | RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
topic | Inorganic Chemistry, Organic Chemistry, Physical and Theoretical Chemistry, Computer Science Applications, Spectroscopy, Molecular Biology, General Medicine, Catalysis |
url | http://dx.doi.org/10.3390/ijms20020350 |